COMMUNIQUÉS West-GlobeNewswire

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update
30/09/2025
Cash position of CHF 2.3 million at end of H1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced [...]
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
30/09/2025
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025 Schlieren (Zürich), Switzerland – September 30, 2025 – Kuros Biosciences (“Kuros” or the “Company”), a leader in innovative [...]

Pages